CStone Pharmaceuticals announced clinical trial results for CS2009 in various cancer types, including Soft Tissue Sarcoma (STS), metastatic colorectal cancer (mCRC), and non-small cell lung cancer (NSCLC), from its base in Suzhou.
1 report, 1 independent
Updated Aug 27
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
CStone Pharmaceuticals announced clinical trial results for CS2009 in various cancer types, including Soft Tissue Sarcoma (STS), metastatic colorectal cancer (mCRC), and non-small cell lung cancer (NSCLC), from its base in Suzhou.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Jason Yang
researcher ORCID 0000-0002-7156-5872
Nothing else this week.